Genmab A/S: Analysts React Positively to the Completion of the Merus Acquisition

Genmab A/S is a pharmaceutical company that operates as a highly specialized innovation hub for antibody therapies that specifically mobilize the human immune system against cancer. The core of the business model is based on proprietary technology platforms such as "DuoBody" and "HexaBody," which enable the development of bispecific antibodies that can bind to two different target molecules simultaneously. The company is transitioning from a research lab that licenses its inventions early and relies on royalties to a fully integrated biotechnology...